IP Library › Assignment 067484/0517
Patent Assignment
Reel/Frame 067484/0517

Change of Name

Recorded: 2024-05-21 Pages: 4
Assignor
EBRIS PHARMA CO.
Executed: 2024-04-01
Assignee
INTERLUDE BIOPHARMA CO.
1450 BRICKELL AVE., MIAMI, FLORIDA, 33131
Covered Property (1)
Oxymetazoline for the Treatment of Ano-Rectal Disorders
Patent: 9,849,114 →
Application: 15/168,432 →
Publication: US 2016/0271110
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 20, 2020
From: BARAK, NIR; RICE, HOWARD LAWRENCE
To: RDD PHARMA LTD.
Reel/Frame 053247/0915 →
Assignment of Assignor's Interest May 21, 2024
From: RDD PHARMA LTD.
To: EBRIS PHARMA CO.
Reel/Frame 067484/0347 →